Humacyte intends to use the net proceeds that it will receive from the offering to fund the commercialization of SYMVESS™ in the vascular trauma indication, the development of the product candidates ...
Cava Group (NYSE: CAVA) stock caught investor attention from the time of its initial public offering (IPO) in the middle of ...
Narratives surrounding CoreWeave's upcoming IPO are echoing that of Snowflake. CoreWeave is not only the first major IPO for ...
Zepto is conducting a secondary share sale of over $200 million to boost domestic ownership from 33% to at least 40% before ...
Vermont Transportation officials are warning drivers of bridge work at the White River Junction Interstate interchange Wednesday morning. Vermont Medal of Honor recipients were honored Tuesday under ...
The fast-paced week in the Iowa legislature known as “Funnel Week” officially concluded on March 7. During this period, all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results